Microbot Medical ROE 2010-2025 | MBOT
Current and historical return on equity (ROE) values for Microbot Medical (MBOT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Microbot Medical ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $-0.01B | $0.03B | -77.61% |
| 2025-03-31 | $-0.01B | $0.03B | -102.33% |
| 2024-12-31 | $-0.01B | $0.00B | -200.00% |
| 2024-09-30 | $-0.01B | $0.00B | -190.48% |
| 2024-06-30 | $-0.01B | $0.01B | -150.00% |
| 2024-03-31 | $-0.01B | $0.01B | -133.33% |
| 2023-12-31 | $-0.01B | $0.01B | -153.85% |
| 2023-09-30 | $-0.01B | $0.01B | -142.86% |
| 2023-06-30 | $-0.01B | $0.01B | -162.96% |
| 2023-03-31 | $-0.01B | $0.01B | -192.59% |
| 2022-12-31 | $-0.01B | $0.01B | -152.94% |
| 2022-09-30 | $-0.01B | $0.01B | -136.59% |
| 2022-06-30 | $-0.01B | $0.01B | -105.66% |
| 2022-03-31 | $-0.01B | $0.01B | -81.25% |
| 2021-12-31 | $-0.01B | $0.01B | -64.86% |
| 2021-09-30 | $-0.01B | $0.02B | -52.38% |
| 2021-06-30 | $-0.01B | $0.02B | -43.48% |
| 2021-03-31 | $-0.01B | $0.02B | -36.00% |
| 2020-12-31 | $-0.01B | $0.02B | -33.33% |
| 2020-09-30 | $-0.01B | $0.03B | -27.59% |
| 2020-06-30 | $-0.01B | $0.03B | -33.33% |
| 2020-03-31 | $-0.01B | $0.03B | -42.11% |
| 2019-12-31 | $-0.01B | $0.03B | -58.18% |
| 2019-09-30 | $-0.01B | $0.01B | -133.33% |
| 2019-06-30 | $-0.01B | $0.01B | -128.00% |
| 2019-03-31 | $-0.01B | $0.01B | -128.00% |
| 2018-12-31 | $-0.01B | $0.00B | -112.00% |
| 2018-09-30 | $-0.01B | $0.01B | -58.82% |
| 2018-06-30 | $0.00B | $0.01B | -41.03% |
| 2018-03-31 | $-0.01B | $0.01B | -54.55% |
| 2017-12-31 | $-0.01B | $0.01B | -61.54% |
| 2017-09-30 | $-0.01B | $0.01B | -141.94% |
| 2017-06-30 | $-0.01B | $0.01B | -258.82% |
| 2017-03-31 | $-0.01B | $0.00B | 2800.00% |
| 2016-12-31 | $-0.01B | $0.00B | 200.00% |
| 2016-09-30 | $0.03B | $0.00B | -742.86% |
| 2016-06-30 | $0.02B | $-0.01B | -1360.00% |
| 2016-03-31 | $0.01B | $-0.01B | 240.00% |
| 2015-12-31 | $0.00B | $0.00B | 0.00% |
| 2015-09-30 | $-0.04B | $0.01B | -569.23% |
| 2015-06-30 | $-0.03B | $0.02B | -342.86% |
| 2015-03-31 | $-0.03B | $0.00B | -800.00% |
| 2014-12-31 | $-0.03B | $0.01B | -488.89% |
| 2014-09-30 | $-0.03B | $0.02B | -333.33% |
| 2014-06-30 | $-0.03B | $0.00B | -566.67% |
| 2014-03-31 | $-0.03B | $0.01B | -311.11% |
| 2013-12-31 | $-0.03B | $0.02B | -273.68% |
| 2013-09-30 | $-0.02B | $0.00B | -237.84% |
| 2013-06-30 | $-0.03B | $0.01B | -295.24% |
| 2013-03-31 | $-0.02B | $0.01B | -252.63% |
| 2012-12-31 | $-0.03B | $0.01B | -373.33% |
| 2012-09-30 | $-0.03B | $0.01B | -474.07% |
| 2012-06-30 | $-0.02B | $0.01B | -250.00% |
| 2012-03-31 | $-0.03B | $0.00B | -227.27% |
| 2011-12-31 | $-0.02B | $0.01B | -135.48% |
| 2011-09-30 | $-0.02B | $0.01B | -139.39% |
| 2011-06-30 | $-0.03B | $0.02B | -133.33% |
| 2011-03-31 | $-0.03B | $0.02B | -120.93% |
| 2010-12-31 | $-0.03B | $0.02B | -113.04% |
| 2010-09-30 | $-0.02B | $0.02B | -82.24% |
| 2010-06-30 | $-0.02B | $0.03B | -77.06% |
| 2010-03-31 | $-0.02B | $0.03B | -85.19% |
| 2009-12-31 | $-0.03B | $0.03B | -101.96% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.141B | $0.000B |
| Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $188.160B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $171.782B | 71.20 |
| IDEXX Laboratories (IDXX) | United States | $50.940B | 53.01 |
| Edwards Lifesciences (EW) | United States | $46.340B | 30.71 |
| Alcon (ALC) | Switzerland | $44.451B | 29.84 |
| IQVIA Holdings (IQV) | United States | $32.700B | 18.48 |
| DexCom (DXCM) | United States | $31.725B | 47.59 |
| Mettler-Toledo (MTD) | United States | $27.244B | 32.34 |
| STERIS (STE) | Ireland | $24.388B | 25.96 |
| Waters (WAT) | United States | $17.722B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.000B | 0.00 |
| Hologic (HOLX) | United States | $15.084B | 16.34 |
| Penumbra (PEN) | United States | $9.875B | 72.14 |
| Sysmex ADR (SSMXY) | Japan | $8.416B | 26.74 |
| Globus Medical (GMED) | United States | $8.261B | 19.06 |
| Masimo (MASI) | United States | $7.973B | 26.83 |
| Teleflex (TFX) | United States | $5.493B | 8.87 |
| Glaukos (GKOS) | United States | $5.221B | 0.00 |
| TransMedics (TMDX) | United States | $4.182B | 63.56 |
| Integer Holdings (ITGR) | United States | $3.723B | 18.58 |
| LivaNova (LIVN) | United Kingdom | $2.920B | 16.71 |
| Alphatec Holdings (ATEC) | United States | $2.338B | 0.00 |
| Veracyte (VCYT) | United States | $2.326B | 32.14 |
| PROCEPT BioRobotics (PRCT) | United States | $2.210B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.118B | 25.29 |
| Artivion (AORT) | United States | $1.983B | 100.05 |
| Elekta AB (EKTAY) | Sweden | $1.850B | 17.30 |
| Integra LifeSciences Holdings (IART) | United States | $1.145B | 6.56 |
| OPKO Health (OPK) | United States | $1.080B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.067B | 0.00 |
| IRadimed (IRMD) | United States | $0.890B | 43.21 |
| Tandem Diabetes Care (TNDM) | United States | $0.736B | 0.00 |
| AxoGen (AXGN) | United States | $0.707B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.690B | 0.00 |
| SiBone (SIBN) | United States | $0.668B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.530B | 9.37 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.472B | 3.79 |
| Treace Medical Concepts (TMCI) | United States | $0.454B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.390B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.386B | 9.82 |
| Delcath Systems (DCTH) | United States | $0.369B | 88.00 |
| RxSight (RXST) | United States | $0.360B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.359B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.287B | 19.78 |
| NeuroPace (NPCE) | United States | $0.273B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.229B | 0.00 |
| Neuronetics (STIM) | United States | $0.223B | 0.00 |
| 908 Devices (MASS) | United States | $0.222B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Inogen (INGN) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.190B | 0.00 |
| Accuray (ARAY) | United States | $0.170B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.132B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.108B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.081B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.075B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 22.67 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.22 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |